People
The EUSA Pharma Board of Directors
Gilles Alberici has 20 years of experience in the European pharmaceutical industry. Gilles obtained his PharmD (1981) from Paris University, and then was resident and researcher in immunology in one of the French leading academic research hospitals (Institut Gustave-Roussy) where he received his PhD (immunotoxicology).
Gilles then served as Development and Manufacturing Director of biological agents in the Mérieux Group. He founded (1994) and managed IMTIX, a Pasteur-Mérieux business unit dedicated to transplantation and haematology. He was then President of IMTIX-SangStat, the European affiliate of SangStat, where he managed more than 140 people in 12 different countries. Gilles is the author of more than 40 publications and 4 issued patents.
Gilles founded OPi in September 1999. Since their inception, he served as President and CEO of OPi SA and its subsidiaries.
|
|
